154 related articles for article (PubMed ID: 23649098)
1. Characteristics and outcomes of patients with vasoplegic versus tissue dysoxic septic shock.
Sterling SA; Puskarich MA; Shapiro NI; Trzeciak S; Kline JA; Summers RL; Jones AE;
Shock; 2013 Jul; 40(1):11-4. PubMed ID: 23649098
[TBL] [Abstract][Full Text] [Related]
2. Classification of Septic Shock Phenotypes Based on the Presence of Hypotension and Hyperlactatemia in Cats.
Troia R; Buzzurra F; Ciuffoli E; Mascalzoni G; Foglia A; Magagnoli I; Dondi F; Giunti M
Front Vet Sci; 2021; 8():692528. PubMed ID: 34595228
[No Abstract] [Full Text] [Related]
3. Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock.
Ranzani OT; Monteiro MB; Ferreira EM; Santos SR; Machado FR; Noritomi DT;
Rev Bras Ter Intensiva; 2013; 25(4):270-8. PubMed ID: 24553507
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel 5-group classification system of sepsis by vasopressor use and initial serum lactate in the emergency department.
Swenson KE; Dziura JD; Aydin A; Reynolds J; Wira CR
Intern Emerg Med; 2018 Mar; 13(2):257-268. PubMed ID: 28132131
[TBL] [Abstract][Full Text] [Related]
5. Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock.
Thomas-Rueddel DO; Poidinger B; Weiss M; Bach F; Dey K; Häberle H; Kaisers U; Rüddel H; Schädler D; Scheer C; Schreiber T; Schürholz T; Simon P; Sommerer A; Schwarzkopf D; Weyland A; Wöbker G; Reinhart K; Bloos F;
J Crit Care; 2015 Apr; 30(2):439.e1-6. PubMed ID: 25466313
[TBL] [Abstract][Full Text] [Related]
6. The Impact of the Sepsis-3 Septic Shock Definition on Previously Defined Septic Shock Patients.
Sterling SA; Puskarich MA; Glass AF; Guirgis F; Jones AE
Crit Care Med; 2017 Sep; 45(9):1436-1442. PubMed ID: 28542029
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of patients excluded by the definition of septic shock based on their lactate levels after initial fluid resuscitation: a prospective multi-center observational study.
Ko BS; Kim K; Choi SH; Kang GH; Shin TG; Jo YH; Ryoo SM; Beom JH; Kwon WY; Han KS; Choi HS; Chung SP; Suh GJ; Lim TH; Kim WY;
Crit Care; 2018 Feb; 22(1):47. PubMed ID: 29475445
[TBL] [Abstract][Full Text] [Related]
8. Septic shock 3.0 criteria application in severe COVID-19 patients: An unattended sepsis population with high mortality risk.
Cidade JP; Coelho LM; Costa V; Morais R; Moniz P; Morais L; Fidalgo P; Tralhão A; Paulino C; Nora D; Valério B; Mendes V; Tapadinhas C; Povoa P
World J Crit Care Med; 2022 Jul; 11(4):246-254. PubMed ID: 36051940
[TBL] [Abstract][Full Text] [Related]
9. A mortality analysis of septic shock, vasoplegic shock and cryptic shock classified by the third international consensus definitions (Sepsis-3).
Yang WS; Kang HD; Jung SK; Lee YJ; Oh SH; Kim YJ; Sohn CH; Kim WY
Clin Respir J; 2020 Sep; 14(9):857-863. PubMed ID: 32438528
[TBL] [Abstract][Full Text] [Related]
10. Emergency department septic shock patient mortality with refractory hypotension vs hyperlactatemia: A retrospective cohort study.
April MD; Donaldson C; Tannenbaum LI; Moore T; Aguirre J; Pingree A; Lantry JH
Am J Emerg Med; 2017 Oct; 35(10):1474-1479. PubMed ID: 28460808
[TBL] [Abstract][Full Text] [Related]
11. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
Shankar-Hari M; Phillips GS; Levy ML; Seymour CW; Liu VX; Deutschman CS; Angus DC; Rubenfeld GD; Singer M;
JAMA; 2016 Feb; 315(8):775-87. PubMed ID: 26903336
[TBL] [Abstract][Full Text] [Related]
12. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
Trials; 2016 Aug; 17():384. PubMed ID: 27484695
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.
Hernández G; Ospina-Tascón GA; Damiani LP; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Granda-Luna V; Cavalcanti AB; Bakker J; ; Hernández G; Ospina-Tascón G; Petri Damiani L; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Cavalcanti AB; Bakker J; Hernández G; Alegría L; Ferri G; Rodriguez N; Holger P; Soto N; Pozo M; Bakker J; Cook D; Vincent JL; Rhodes A; Kavanagh BP; Dellinger P; Rietdijk W; Carpio D; Pavéz N; Henriquez E; Bravo S; Valenzuela ED; Vera M; Dreyse J; Oviedo V; Cid MA; Larroulet M; Petruska E; Sarabia C; Gallardo D; Sanchez JE; González H; Arancibia JM; Muñoz A; Ramirez G; Aravena F; Aquevedo A; Zambrano F; Bozinovic M; Valle F; Ramirez M; Rossel V; Muñoz P; Ceballos C; Esveile C; Carmona C; Candia E; Mendoza D; Sanchez A; Ponce D; Ponce D; Lastra J; Nahuelpán B; Fasce F; Luengo C; Medel N; Cortés C; Campassi L; Rubatto P; Horna N; Furche M; Pendino JC; Bettini L; Lovesio C; González MC; Rodruguez J; Canales H; Caminos F; Galletti C; Minoldo E; Aramburu MJ; Olmos D; Nin N; Tenzi J; Quiroga C; Lacuesta P; Gaudín A; Pais R; Silvestre A; Olivera G; Rieppi G; Berrutti D; Ochoa M; Cobos P; Vintimilla F; Ramirez V; Tobar M; García F; Picoita F; Remache N; Granda V; Paredes F; Barzallo E; Garcés P; Guerrero F; Salazar S; Torres G; Tana C; Calahorrano J; Solis F; Torres P; Herrera L; Ornes A; Peréz V; Delgado G; López A; Espinosa E; Moreira J; Salcedo B; Villacres I; Suing J; Lopez M; Gomez L; Toctaquiza G; Cadena Zapata M; Orazabal MA; Pardo Espejo R; Jimenez J; Calderón A; Paredes G; Barberán JL; Moya T; Atehortua H; Sabogal R; Ortiz G; Lara A; Sanchez F; Hernán Portilla A; Dávila H; Mora JA; Calderón LE; Alvarez I; Escobar E; Bejarano A; Bustamante LA; Aldana JL
JAMA; 2019 Feb; 321(7):654-664. PubMed ID: 30772908
[TBL] [Abstract][Full Text] [Related]
14. Association between hemodynamic presentation and outcome in sepsis patients.
Hwang SY; Shin TG; Jo IJ; Jeon K; Suh GY; Lee TR; Cha WC; Sim MS; Song KJ; Jeong YK
Shock; 2014 Sep; 42(3):205-10. PubMed ID: 24978884
[TBL] [Abstract][Full Text] [Related]
15. The effect of early quantitative resuscitation on organ function in survivors of septic shock.
Sterling SA; Puskarich MA; Summers RL; Jones AE
J Crit Care; 2015 Apr; 30(2):261-3. PubMed ID: 25465026
[TBL] [Abstract][Full Text] [Related]
16. Varying Presentations and Outcomes of Septic Shock: Should Septic Shock Be Stratified?
Zhu Y; Yin H; Zhang R; Ye X; Wei J
Am Surg; 2017 Nov; 83(11):1235-1240. PubMed ID: 29183525
[TBL] [Abstract][Full Text] [Related]
17. Septic shock-3 vs 2: an analysis of the ALBIOS study.
Vasques F; Duscio E; Romitti F; Pasticci I; Caironi P; Meessen J; Latini R; Cressoni M; Camporota L; Pesenti A; Fumagalli R; Quintel M; Gattinoni L
Crit Care; 2018 Sep; 22(1):237. PubMed ID: 30261898
[TBL] [Abstract][Full Text] [Related]
18. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
[TBL] [Abstract][Full Text] [Related]
19. Earliest Bedside Assessment of Hemodynamic Parameters and Cardiac Biomarkers: Their Role as Predictors of Adverse Outcome in Patients with Septic Shock.
Sasko B; Butz T; Prull MW; Liebeton J; Christ M; Trappe HJ
Int J Med Sci; 2015; 12(9):680-8. PubMed ID: 26392804
[TBL] [Abstract][Full Text] [Related]
20. Serial blood lactate levels can predict the development of multiple organ failure following septic shock.
Bakker J; Gris P; Coffernils M; Kahn RJ; Vincent JL
Am J Surg; 1996 Feb; 171(2):221-6. PubMed ID: 8619454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
